News Archives

News Archives

Wednesday, April 16, 2008

BTS India Private Equity Fund Limited, a Mauritius based Company registered with the Securities and Exchange Board of India (SEBI) as Foreign Venture Capital Investor has invested around USD 7 million in the Company by way of private placement of shares.

PDL received Certificate of suitability from the office of European Directorate for the Quality of Medicines & HealthCare, France

Tuesday, July 17, 2007

PDL received Certificate of suitability from the office of European Directorate for the Quality of Medicines & HealthCare, France Monday July16,2007 The Director of European Directorate for the Quality of Medicines & HealthCare has issued certificate of suitability no.RO-CEP 2005-064-Rev 00 to the Company for its product-Flucloxacillin Sodium.

Tuesday, April 10, 2007

PDL commission’s state of the art facilities for the manufacture of Betalactum & Cephalosporins Steriles.

Minivet, a Mauritius based FII picks up 4.93% stake in PDL

Saturday, September 16, 2006

Parabolic Drugs Limited allotted 4,00,000 Optionally Convertible Cumulative Preference shares of the face value of Rs. 100/- each to Minivet Limited a Mauritius based Foreign Institution Investors on private placement of shares of the Company.

 

PDL's Panchkula facility is USFDA approved

Saturday, September 16, 2006

Parabolic Drugs Limited has been granted permission to its Panchkula Facility for the supplies to US markets